Statistics
Publications
35
Citations
5.3K
H-Index
26
Active since
2001
Eva Lin is an author at Gene Therapy Laboratory specializing in oncology, medicine, and molecular oncology.
Publications per year
2001–2025
35
35
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Timothy R. Wilson, Jane Fridlyand, Yibing Yan et al. · Nature · 2012 · 1.1K citations
Medicine, Cancer Biology, Oncology +16
A role for alpha-synuclein in the regulation of dopamine biosynthesis.
Ruth G. Perez, Jack C. Waymire, Eva Lin et al. · PubMed · 2002 · 632 citations · Full text
A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Ruth G. Perez, Jack C. Waymire, Eva Lin et al. · Journal of Neuroscience · 2002 · 588 citations · Full text
USP7 small-molecule inhibitors interfere with ubiquitin binding
Lorna Kategaya, Paola Di Lello, Lionel Rougé et al. · Nature · 2017 · 346 citations · Full text
Reproducible pharmacogenomic profiling of cancer cell line panels
Peter M. Haverty, Eva Lin, Jenille Tan et al. · Nature · 2016 · 307 citations
Medicine, Oncology, Pharmacology +14
1–5 of 35